Dr. Natan Pedram Davoudzadeh, MD

Dr. Davoudzadeh practices at St. John's Episcopal Hospital in Far Rockaway, New York, part of Episcopal Health Services.

Dr. Davoudzadeh's NPI, 1487911517, was assigned on April 13, 2012. Dr. Davoudzadeh graduated from State University of New York Downstate Medical Center College of Medicine in 2012. Dr. Davoudzadeh holds New York license 289608.

Dr. Davoudzadeh's primary practice is St. John's Episcopal Hospital, at 327 Beach 19th Street, Far Rockaway, NY 11691 in Queens County. The practice phone is (718) 869-7000.

Dr. Davoudzadeh's primary practice is St. John's Episcopal Hospital in Far Rockaway, New York, part of Episcopal Health Services. Dr. Davoudzadeh is also affiliated with North Shore University Hospital. The medical group on file is St. John's Medical Group. Dmand AI also links Dr. Davoudzadeh to 1 more hospital, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davoudzadeh practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Davoudzadeh's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Davoudzadeh is licensed in New York.

CMS data shows 1,642 Medicare services from Dr. Davoudzadeh across 22 procedure codes in 2024, for 383 Medicare patients. Medicare paid $114,035 for them.

CMS counts 383 Medicare patients who saw Dr. Davoudzadeh in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Davoudzadeh's median patient age at 64, with 27% women.

In 2024, Dr. Davoudzadeh wrote 1,301 Medicare Part D claims for 496 patients. 88% of them were for generic drugs. CMS names the drug for 1,166 of them, across 19 drugs with 11 or more claims each, at $675,105 in total drug cost. In 2023, CMS named 934 claims across 20 drugs.

Dr. Davoudzadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Davoudzadeh as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Davoudzadeh, published from 2017 to 2019. The most frequent topics are Nephrectomy and Robotic Surgical Procedures. Dr. Davoudzadeh's most frequent co-authors are Olamide Omidele, Michael A. Palese, MD and Ethan P. Davoudzadeh, MD.

CMS Open Payments shows 176 general payments to Dr. Davoudzadeh from 34 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 75% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,038.

Dr. Davoudzadeh graduated from State University of New York Downstate Medical Center College of Medicine in 2012.